XML 36 R23.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders' Equity | 3 Months Ended
--- | ---
Mar. 31, 2025
Stockholders' Equity |
Stockholders' Equity | 16. Stockholders’ Equity Common Stock Dividends ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended March 31,
​ |  | 2025 |  | 2024
​ | ​ | ​ | ​ | ​ | ​ | ​
Dividends declared per common share | ​ | $ | 0.75 |  | $ | 0.69
​ Reconciliation of Outstanding Common Shares ​
​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended March 31,
​ |  | 2025 |  | 2024
Beginning balance |  | 226,225,161 |  | 236,438,294
Shares issued |  | 1,635,250 | ​ | 1,515,728
Treasury stock acquired |  | (2,888,696) | ​ | (2,921,241)
Ending balance |  | 224,971,715 | ​ | 235,032,781
​ In January 2022, our Board of Directors (“Board”) authorized a $1.6 billion increase to the June 2021 share repurchase program authorization, which was completed in April 2024. In February 2024, our Board authorized a share repurchase program of up to $1.5 billion of our outstanding common stock, which has no expiration date. In February 2025, our Board authorized a share repurchase program of up to $1.5 billion of our outstanding common stock, which has no expiration date. Shares repurchased under these programs are accounted for as treasury stock, carried at cost and reflected as a reduction to stockholders’ equity. Other Comprehensive Income ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended March 31, 2025
​ |  | Pre-Tax |  | Tax |  | After-Tax
​ | ​ | (in millions)
Net unrealized gains on available-for-sale securities during the period | ​ | $ | 666.8 | ​ | $ | (140.9) | ​ | $ | 525.9
Reclassification adjustment for losses included in net income (1) | ​ |  | 62.5 | ​ | ​ | (13.1) | ​ | ​ | 49.4
Adjustments for assumed changes in amortization patterns | ​ |  | (0.4) | ​ | ​ | 0.1 | ​ | ​ | (0.3)
Adjustments for assumed changes in policyholder liabilities | ​ |  | 18.3 | ​ | ​ | (3.9) | ​ | ​ | 14.4
Net unrealized gains on available-for-sale securities | ​ |  | 747.2 | ​ | ​ | (157.8) | ​ | ​ | 589.4
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net unrealized gains on derivative instruments during the period | ​ |  | 18.5 | ​ | ​ | (3.9) | ​ | ​ | 14.6
Reclassification adjustment for gains included in net income (2) | ​ |  | (0.6) | ​ | ​ | 0.1 | ​ | ​ | (0.5)
Net unrealized gains on derivative instruments | ​ | ​ | 17.9 | ​ | ​ | (3.8) | ​ | ​ | 14.1
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liability for future policy benefits discount rate remeasurement loss (3) | ​ | ​ | (312.4) | ​ | ​ | 62.6 | ​ | ​ | (249.8)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Market risk benefit nonperformance risk remeasurement gain (4) | ​ | ​ | 2.7 | ​ | ​ | (0.6) | ​ | ​ | 2.1
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign currency translation adjustment | ​ | ​ | 74.1 | ​ | ​ | (0.7) | ​ | ​ | 73.4
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amortization of amounts included in net periodic benefit cost (5) | ​ |  | 3.8 | ​ | ​ | (0.9) | ​ | ​ | 2.9
Net unrecognized postretirement benefit obligation | ​ |  | 3.8 | ​ | ​ | (0.9) | ​ | ​ | 2.9
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other comprehensive income | ​ | $ | 533.3 | ​ | $ | (101.2) | ​ | $ | 432.1
​ ​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended March 31, 2024
​ |  | Pre-Tax |  | Tax |  | After-Tax
​ | ​ | (in millions)
Net unrealized losses on available-for-sale securities during the period | ​ | $ | (507.7) | ​ | $ | 108.3 | ​ | $ | (399.4)
Reclassification adjustment for losses included in net income (1) | ​ |  | 43.5 | ​ |  | (9.0) | ​ | ​ | 34.5
Adjustments for assumed changes in amortization patterns | ​ |  | (0.2) | ​ |  | — | ​ | ​ | (0.2)
Adjustments for assumed changes in policyholder liabilities | ​ |  | 8.2 | ​ |  | (1.7) | ​ | ​ | 6.5
Net unrealized losses on available-for-sale securities | ​ |  | (456.2) | ​ |  | 97.6 | ​ | ​ | (358.6)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net unrealized gains on derivative instruments during the period | ​ |  | 23.1 | ​ |  | (4.8) | ​ | ​ | 18.3
Reclassification adjustment for gains included in net income (2) | ​ |  | (0.9) | ​ |  | 0.2 | ​ | ​ | (0.7)
Adjustments for assumed changes in amortization patterns | ​ | ​ | (0.1) | ​ | ​ | — | ​ | ​ | (0.1)
Net unrealized gains on derivative instruments | ​ |  | 22.1 | ​ |  | (4.6) | ​ | ​ | 17.5
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liability for future policy benefits discount rate remeasurement gain (3) | ​ | ​ | 710.2 | ​ | ​ | (155.5) | ​ | ​ | 554.7
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Market risk benefit nonperformance risk remeasurement loss (4) | ​ | ​ | (11.0) | ​ | ​ | 2.3 | ​ | ​ | (8.7)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign currency translation adjustment | ​ | ​ | (116.7) | ​ | ​ | (4.3) | ​ | ​ | (121.0)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amortization of amounts included in net periodic benefit cost (5) | ​ |  | 4.8 | ​ | ​ | (1.3) | ​ | ​ | 3.5
Net unrecognized postretirement benefit obligation | ​ |  | 4.8 | ​ | ​ | (1.3) | ​ | ​ | 3.5
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other comprehensive income | ​ | $ | 153.2 | ​ | $ | (65.8) | ​ | $ | 87.4
(1) | Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) and net realized capital gains (losses) on funds withheld assets on the consolidated statements of operations.
(2) | See Note 5, Derivative Financial Instruments, under the caption “Effect of Fair Value and Cash Flow Hedges on Consolidated Statements of Operations” for further details.
(3) | Includes the discount rate remeasurement gain (loss) associated with the LFPB and the associated reinsurance recoverable. See Note 9, Future Policy Benefits and Claims, under the caption “Liability for Future Policy Benefits” for further details.
(4) | See Note 10, Market Risk Benefits, for further details.
(5) | Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 14, Employee and Agent Benefits, under the caption “Components of Net Periodic Benefit Cost” for further details.
Accumulated Other Comprehensive Loss ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | MRB | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Net unrealized | ​ | Net unrealized | ​ | LFPB | ​ | nonperformance | ​ | Foreign | ​ | Unrecognized | ​ | Accumulated
​ | ​ | losses on | ​ | gains (losses) | ​ | discount rate | ​ | risk | ​ | currency | ​ | postretirement | ​ | other
​ | ​ | available-for-sale | ​ | on derivative | ​ | remeasurement | ​ | remeasurement | ​ | translation | ​ | benefit | ​ | comprehensive
​ |  | securities (1) |  | instruments |  | gain |  | loss |  | adjustment |  | obligation |  | loss
​ | ​ | (in millions)
Balances as of January 1, 2024 | ​ | $ | (4,014.8) | ​ | $ | (2.1) | ​ | $ | 428.2 | ​ | $ | (6.9) | ​ | $ | (1,498.0) | ​ | $ | (251.7) | ​ | $ | (5,345.3)
Other comprehensive income during the period, net of adjustments | ​ |  | (393.1) | ​ | ​ | 18.2 | ​ | ​ | 554.7 | ​ | ​ | (8.7) | ​ | ​ | (119.2) | ​ | ​ | — | ​ | ​ | 51.9
Amounts reclassified from AOCI | ​ |  | 34.5 | ​ | ​ | (0.7) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 3.5 | ​ | ​ | 37.3
Other comprehensive income | ​ |  | (358.6) | ​ | ​ | 17.5 | ​ | ​ | 554.7 | ​ | ​ | (8.7) | ​ | ​ | (119.2) | ​ | ​ | 3.5 | ​ | ​ | 89.2
Balances as of March 31, 2024 | ​ | $ | (4,373.4) | ​ | $ | 15.4 | ​ | $ | 982.9 | ​ | $ | (15.6) | ​ | $ | (1,617.2) | ​ | $ | (248.2) | ​ | $ | (5,256.1)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balances as of January 1, 2025 | ​ | $ | (4,692.9) | ​ | $ | 51.8 | ​ | $ | 1,438.2 | ​ | $ | (15.0) | ​ | $ | (1,785.9) | ​ | $ | (221.0) | ​ | $ | (5,224.8)
Other comprehensive income during the period, net of adjustments | ​ |  | 540.0 | ​ | ​ | 14.6 | ​ | ​ | (249.8) | ​ | ​ | 2.1 | ​ | ​ | 80.2 | ​ | ​ | — | ​ | ​ | 387.1
Amounts reclassified from AOCI | ​ |  | 49.4 | ​ | ​ | (0.5) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 2.9 | ​ | ​ | 51.8
Other comprehensive income | ​ |  | 589.4 | ​ | ​ | 14.1 | ​ | ​ | (249.8) | ​ | ​ | 2.1 | ​ | ​ | 80.2 | ​ | ​ | 2.9 | ​ | ​ | 438.9
Balances as of March 31, 2025 | ​ | $ | (4,103.5) | ​ | $ | 65.9 | ​ | $ | 1,188.4 | ​ | $ | (12.9) | ​ | $ | (1,705.7) | ​ | $ | (218.1) | ​ | $ | (4,785.9)
(1) | Net unrealized losses on available-for-sale securities for which an allowance for credit loss has been recorded were $4.0 million and $2.5 million as of March 31, 2025 and 2024, respectively.
​ Noncontrolling Interest Interests held by unaffiliated parties in consolidated entities are reflected in noncontrolling interest, which represents the noncontrolling partners’ share of the underlying net assets of our consolidated subsidiaries. Noncontrolling interest that is not redeemable is reported in the equity section of the consolidated statements of financial position. The noncontrolling interest holders in certain of our consolidated entities maintain an equity interest that is redeemable at the option of the holder, which may be exercised on varying dates. Since redemption of the noncontrolling interest is outside of our control, this interest is excluded from stockholders’ equity and reported separately as redeemable noncontrolling interest on the consolidated statements of financial position. Our redeemable noncontrolling interest primarily relates to consolidated sponsored investment funds for which interests are redeemed at fair value from the net assets of the funds. For our redeemable noncontrolling interest related to other consolidated subsidiaries, redemptions are required to be purchased at fair value or a value based on a formula that management intended to reasonably approximate fair value based on a fixed multiple of earnings over a measurement period. The carrying value of the redeemable noncontrolling interest is compared to the redemption value at each reporting period. Any adjustments to the carrying amount of the redeemable noncontrolling interest for changes in redemption value prior to exercise of the redemption option are determined after the attribution of net income or loss of the subsidiary and are recognized in the redemption value as they occur. Adjustments to the carrying value of redeemable noncontrolling interest result in adjustments to additional paid-in capital and/or retained earnings. Adjustments are recorded in retained earnings to the extent the redemption value of the redeemable noncontrolling interest exceeds its fair value and will impact the numerator in our earnings per share calculations. All other adjustments to the redeemable noncontrolling interest are recorded in additional paid-in capital. Following is a reconciliation of the changes in the redeemable noncontrolling interest: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended March 31,
​ |  | 2025 |  | 2024
​ | ​ | (in millions)
Balance at beginning of period | ​ | $ | 337.7 | ​ | $ | 248.9
Net income (loss) attributable to redeemable noncontrolling interest | ​ | ​ | 11.5 | ​ | ​ | (2.0)
Redeemable noncontrolling interest of deconsolidated entities (1) | ​ | ​ | (12.5) | ​ | ​ | (90.0)
Contributions from redeemable noncontrolling interest | ​ | ​ | 30.8 | ​ | ​ | 226.2
Distributions to redeemable noncontrolling interest | ​ | ​ | (31.8) | ​ | ​ | (14.2)
Purchase of subsidiary shares from redeemable noncontrolling interest | ​ | ​ | (1.6) | ​ | ​ | —
Change in redemption value of redeemable noncontrolling interest | ​ | ​ | — | ​ | ​ | 2.1
Other comprehensive loss attributable to redeemable noncontrolling interest | ​ | ​ | (7.4) | ​ | ​ | (0.2)
Balance at end of period | ​ | $ | 326.7 | ​ | $ | 370.8
(1) | We deconsolidated certain sponsored investment funds as they no longer met the requirements for consolidation.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration